ENSG ENSIGN GROUP, INC
Services-Skilled Nursing Care Facilities · Nasdaq · SEC CIK 1125376 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY17.5%
TTM net income YoY21.6%
TTM EPS YoY20.2%
Revenue 3-yr CAGR16.8%
Net income 3-yr CAGR17.2%
Margins
Gross margin21.2%
Operating margin9.0%
Net margin7.0%
FCF margin—
EBITDA margin11.1%
Returns
ROE17.1%
ROA7.1%
ROIC (approx.)18.0%
Asset turnover1.01x
Leverage & solvency
Liabilities / assets57.3%
Debt / equity0.08x
Current ratio1.20x
Interest coverage62.81x
Cash quality & payout
Operating cash flow / net income1.74x
Accruals ratio-5.3%
Payout ratio3.8%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.06B | $4.26B |
| Cost of revenue | $4.02B | $3.38B |
| Gross profit | $1.04B | $883.60M |
| SG&A expense | $269.82M | $225.14M |
| Operating income | $425.31M | $358.30M |
| Interest expense | $7.99M | $8.29M |
| Pretax income | $455.62M | $386.09M |
| Income tax | $111.36M | $87.64M |
| Net income | $343.97M | $297.97M |
| EBITDA | $529.63M | $442.44M |
| EPS (basic) | 6.00 | 5.26 |
| EPS (diluted) | 5.84 | 5.12 |
| Dividends declared per share | 0.25 | 0.24 |
| Weighted avg. shares (diluted) | 58.87M | 58.24M |
| Balance sheet | ||
| Cash & equivalents | $503.88M | $464.60M |
| Short-term investments | $68.51M | $62.26M |
| Receivables | $636.99M | $569.90M |
| Current assets | $1.27B | $1.16B |
| PP&E, net | $1.70B | $1.29B |
| Goodwill | $97.98M | $97.98M |
| Intangibles | $6.38M | $7.29M |
| Total assets | $5.46B | $4.67B |
| Current liabilities | $894.35M | $743.43M |
| Short-term debt | $4.23M | $4.09M |
| Long-term debt | $137.53M | $141.59M |
| Total debt | $141.76M | $145.67M |
| Total liabilities | $3.23B | $2.83B |
| Shareholders' equity | $2.23B | $1.84B |
| Net debt | -$362.12M | -$318.93M |
| Shares outstanding | 58.09M | 57.44M |
| Cash flow statement | ||
| Operating cash flow | $564.27M | $347.19M |
| Investing cash flow | -$513.18M | -$390.05M |
| Financing cash flow | -$11.81M | -$2.16M |
| Depreciation & amortization | $104.33M | $84.14M |
| Stock-based compensation | $48.30M | $36.23M |
| Dividends paid | $14.41M | $13.67M |
| Share buybacks | $20.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.